Purpose Of Review: This review is timely given the 2018 publication of the first international Consensus Statement for the diagnosis and management of pseudohypoparathyroidism (PHP) and related disorders. The purpose of this review is to provide the knowledge needed to recognize and manage PHP1A, pseudopseudohypoparathyroidism (PPHP) and PHP1B - the most common of the subtypes - with an overview of the entire spectrum and to provide a concise summary of management for clinical use. This review will draw from recent literature as well as personal experience in evaluating hundreds of children and adults with PHP.
Recent Findings: Progress is continually being made in understanding the mechanisms underlying the PHP spectrum. Every year, through clinical and laboratory studies, the phenotypes are elucidated in more detail, as are clinical issues such as short stature, brachydactyly, subcutaneous ossifications, cognitive/behavioural impairments, obesity and metabolic disturbances. Headed by a European PHP consortium, experts worldwide published the first international Consensus that provides detailed guidance in a systematic manner and will lead to exponential progress in understanding and managing these disorders.
Summary: As more knowledge is gained from clinical and laboratory investigations, the mechanisms underlying the abnormalities associated with PHP are being uncovered as are improvements in management.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641088 | PMC |
| http://dx.doi.org/10.1097/MOP.0000000000000783 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pseudohypoparathyroidism type 1A presenting as short stature and congenital hypothyroidism.
Endocrinol Diabetes Metab Case Rep
January 2025
Summary: Short stature is a common complaint among pediatric visits and the differential diagnosis is extensive. Although some variations in growth are normal, deviation from normal growth is often the first symptom of chronic disease in children. This is true for hormone abnormalities including growth hormone deficiency, hypothyroidism and glucocorticoid excess.
View Article and Find Full Text PDFGenotype-Phenotype Correlation of GNAS Gene: Review and Disease Management of a Hotspot Mutation.
Int J Mol Sci
October 2024
Medical and Laboratory Genetics Unit, A.O.R.N. "Antonio Cardarelli", 80131 Naples, Italy.
Article Synopsis
- Defects in a specific gene are primarily linked to pseudohypoparathyroidism Ia (PHP1a), with various mutation types identified across all 13 exons.
- A noteworthy mutation, a 4 bp deletion c.565_568delGACT, is recognized as a mutation hotspot, though focused studies on this variant have been limited.
- The authors reported two PHP1a cases related to this deletion and found that patients with the c.565_568delGACT mutation exhibited a higher prevalence of certain characteristics—like brachydactyly and intellectual disability—compared to those with other mutations, suggesting a need for tailored patient monitoring.
Case report: Familial hypoparathyroidism with elevated parathyroid hormone due to an inactivating mutation.
Front Endocrinol (Lausanne)
October 2024
Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Article Synopsis
- This report investigates a family with familial isolated hypoparathyroidism (FIH), highlighting a specific mutation that leads to high levels of functionally inactive parathyroid hormone (PTH) in a 34-year-old woman and her siblings.* -
- The siblings were diagnosed with pseudohypoparathyroidism type 1b, characterized by chronic low calcium levels and elevated PTH, but without the typical features of related disorders.* -
- Treatment with teriparatide, a recombinant human PTH, successfully normalized calcium levels and improved wellbeing for the patient, indicating that inactive variants of PTH can lead to complex hypocalcemia cases.*
Pseudohypoparathyroidism leading to bilateral hip fracture: A case report.
Radiol Case Rep
November 2024
Department of Internal Medicine, Nishtar Medical University, Multan, Punjab, Pakistan.
Article Synopsis
- Pseudohypoparathyroidism (PHP) is a disorder where the body is resistant to parathyroid hormone, causing high PTH levels, low calcium, and high phosphate, leading to various health issues.
- The most common subtype, PHP type 1a, causes symptoms like short stature and electrolyte imbalances, which can result in conditions like seizures or fractures.
- A case study of a 22-year-old woman with PHP highlights her severe symptoms, diagnosis process, and treatment plan, including calcium and Vitamin D supplementation after managing her fractures.
Characterization of Digestive Manifestations in Patients with Impaired PTH/PTHrP Signaling Disorder/Pseudohypoparathyroidism.
Horm Res Paediatr
August 2024
Pediatric Nutrition and Gastroenterology Department, Reference Center for Rare Disorders, PRADORT (Syndrome de PRADer-Willi et autres Obésités Rares avec Troubles du comportement alimentaire), Trousseau Hospital, AP-HP, Sorbonne University, Paris, France.
Article Synopsis
- Pseudohypoparathyroidism is a rare condition linked to issues with the GNAS gene, leading to resistance to certain hormones and symptoms like short stature, obesity, and ossifications.
- This study aimed to investigate the frequency of digestive problems, particularly constipation, in children with iPPSD types 2 and 3, involving 36 patients aged 2 to 18 years.
- Results revealed that over 60% of participants reported constipation, with only a small percentage finding treatment effective, while other digestive issues like vomiting and food selectivity were also common.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!